Subramanian Ramaswamy, Chettri Nikita, Bisaralli Rahul, Bansa Purna, Mamadapur Mahabaleshwar
Department of Clinical Immunology and Rheumatology, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru, India.
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreeshwara Nagar, Mysuru, Karnataka, India.
Mediterr J Rheumatol. 2024 Dec 31;35(4):680-683. doi: 10.31138/mjr.08424.mia. eCollection 2024 Dec.
Methotrexate-induced nodulosis, also known as methotrexate-induced accelerated nodulosis (MIAN), is a rare side effect of methotrexate therapy. Methotrexate (MTX) is commonly used to treat various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. In this case series, we present patients with MIAN, discussing their clinical features, diagnostic approaches, and management strategies. We aim to increase recognition of this rare side effect of MTX therapy, facilitate early diagnosis, and improve clinical management, thus minimising the burden of this debilitating complication on affected individuals.
甲氨蝶呤诱发的结节病,也称为甲氨蝶呤诱发的加速性结节病(MIAN),是甲氨蝶呤治疗的一种罕见副作用。甲氨蝶呤(MTX)常用于治疗各种自身免疫性疾病,如类风湿性关节炎、银屑病和炎症性肠病。在本病例系列中,我们展示了患有MIAN的患者,讨论了他们的临床特征、诊断方法和管理策略。我们旨在提高对MTX治疗这种罕见副作用的认识,促进早期诊断,并改善临床管理,从而将这种使人衰弱的并发症对受影响个体的负担降至最低。